Back
BRCA1HGNC PubMedFunctional SNV

Saturation genome editing of BRCA1 across cell types improves interpretation of variant pathogenicity

Dace P, Forrester NM, Zanti M, et al. — Nat Genet 2026 · November 2026
Relevance score
7/10
Disease / domain
Hereditary breast and ovarian cancer predisposition (BRCA1)
Source
PubMed
PMID 43015421

Gene / mechanism

BRCA1

BRCA1 single-nucleotide variants assessed by saturation genome editing; hypomorphic variants with cell-type-dependent effects

Summary

Over half of reported single-nucleotide variants in BRCA1 lack a definitive clinical interpretation, and the consistency of their effects across cell types had been little explored. The authors performed saturation genome editing (SGE) of BRCA1 in HAP1 cells, scoring 4,113 previously unassayed variants, and developed an SGE assay in human mammary epithelial cells (HMECs) to compare effects across cell lines, drug treatments and genetic backgrounds. In total, 538 variants impair gene function through distinct mechanisms, and HAP1 function scores discriminate known pathogenic from benign variants with near-perfect accuracy. Yet nearly half of HAP1 loss-of-function variants score neutrally in HMECs: these discordant variants are hypomorphic and confer intermediate cancer risk.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

A first SGE of BRCA1 was published in Nature in 2018; this work extends its coverage and, above all, shows that a score obtained in a single cell line can overstate a variant's effect. For the laboratory, these scores provide functional evidence that can be used directly when interpreting BRCA1 variants of uncertain significance, a gene already captured by exome and genome sequencing. The category of hypomorphic variants with intermediate risk, however, raises a genetic counselling question that the usual pathogenicity classes do not resolve.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 3/3Evidence 2/3Novelty 1/2Sample 0/1Publication 1/1

Clinical impact: 3/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 0/1 · Publication status: 1/1 → Total: 7/10

Keywords

BRCA1saturation genome editingfunctional evidencevariant of uncertain significancebreast cancer

More articles on BRCA1

Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime